Mitchell Shawnte

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 36% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mitchell Shawnte's trades of Olema Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
91.50
Quantity 28,987
Value US$2,810,338
Transaction date
Proposed sale
Price
23.01
Quantity 15,000
Value US$345,153
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-04
S Sale
90,252 -7.2%
319.63
US$1,335,932 		90,252 -7.2% 319.63 US$1,335,932
2026-03-05 2026-03-04
S Sale
92,452 -11.4%
296.78
US$204,764 		92,452 -11.4% 296.78 US$204,764
2026-03-04 2026-03-04
PrS Proposed sale
28,987
91.50
US$2,810,338 		28,987 91.50 US$2,810,338
2026-03-05 2026-03-03
S Sale
15,000 -100.0%
23.01
US$345,150 		15,000 -100.0% 23.01 US$345,150
2026-03-03 2026-03-03
PrS Proposed sale
15,000
23.01
US$345,153 		15,000 23.01 US$345,153